
Eli Lilly's Experimental Weight Loss Drug Shows 28% Weight Reduction in Trial
Eli Lilly reported that participants in a late-stage trial of retatrutide lost an average of 28% of their body weight after 80 weeks of treatment.

Eli Lilly reported that participants in a late-stage trial of retatrutide lost an average of 28% of their body weight after 80 weeks of treatment.

The Long Island Rail Road experiences its first strike in decades over wages and health benefits, affecting hundreds of thousands of daily riders.

The FDA has approved bemotrizinol, a sunscreen ingredient widely used overseas, marking the first addition to permitted ingredients since the late 1990s.

The World Health Organization confirmed seven cases of hantavirus infection aboard a cruise ship, highlighting the rare but serious nature of the disease.

A Canadian who was aboard the MV Hondius cruise ship has tested positive for hantavirus, becoming the first confirmed case among four passengers quarantining in British Columbia.

A woman in her 30s suffered serious arm and leg injuries in a shark attack at Coogee Beach in Sydney, marking another incident in recent Australian waters.

European authorities plan evacuations from cruise ship MV Hondius after hantavirus outbreak kills ornithologist, ship to dock in Canary Islands.

New research published in the Journal of Studies on Alcohol and Drugs suggests Americans should limit alcohol consumption to one drink per day.

New research reveals health risks from processed meat consumption and cancer-causing benzene found in popular acne treatments.

British medical organizations and parents identify social media as primary risk to children's wellbeing in new reports.
A pill version of Novo Nordisk's obesity drug Wegovy has generated a waiting list of 10,000 people in the United Kingdom.

Food and Drug Administration analysis finds no definitive connection between COVID-19 vaccines and child fatalities.

Texas Children's Hospital agrees to establish detransition clinic, dismiss five physicians, and pay $10 million in settlement with state.

Pfizer's experimental monthly obesity injection demonstrated a side effect profile comparable to existing GLP-1 drugs in mid-stage trials.

Uganda confirmed three additional Ebola cases while residents in eastern Congo attacked and burned part of a treatment facility amid ongoing outbreak concerns.
Page 4 of 42 (620 stories)